Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $96.0000 (1.32%) ($95.0100 - $97.0800) on Tue. Feb. 11, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.36% (three month average) | RSI | 65 | Latest Price | $96.0000(1.32%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV advances 2.6% a day on average for past five trading days. | Weekly Trend | ABBV advances 4.4% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(63%) SPLV(54%) DIA(53%) VYM(53%) IVE(52%) | Factors Impacting ABBV price | ABBV will decline at least -0.68% in a week (0% probabilities). VIXM(-36%) VXX(-14%) TLT(-14%) UUP(-0%) SHY(2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.68% (StdDev 1.36%) | Hourly BBV | 0.9 () | Intraday Trend | 0.9% | | | |
|
5 Day Moving Average | $91.37(5.07%) | 10 Day Moving Average | $87.26(10.02%) | 20 Day Moving Average | $86.86(10.52%) | To recent high | 0% | To recent low | 18.5% | Market Cap | $169.371b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |